1. Home
  2. MCS vs SLBT Comparison

MCS vs SLBT Comparison

Compare MCS & SLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marcus Corporation (The)

MCS

Marcus Corporation (The)

HOLD

Current Price

$28.10

Market Cap

853.4M

ML Signal

HOLD

Logo SL Science Holding Limited Ordinary Shares

SLBT

SL Science Holding Limited Ordinary Shares

N/A

Current Price

$1.57

Market Cap

942.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MCS
SLBT
Founded
1935
N/A
Country
United States
Taiwan
Employees
N/A
20
Industry
Movies/Entertainment
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
853.4M
942.1M
IPO Year
1994
2025

Fundamental Metrics

Financial Performance
Metric
MCS
SLBT
Price
$28.10
$1.57
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $23.33
N/A
AVG Volume (30 Days)
★ 174.1K
79.0K
Earning Date
04-30-2026
N/A
Dividend Yield
★ 1.69%
N/A
EPS Growth
N/A
N/A
EPS
★ 0.77
N/A
Revenue
★ $758,458,000.00
N/A
Revenue This Year
$12.05
N/A
Revenue Next Year
$3.15
N/A
P/E Ratio
$36.70
★ N/A
Revenue Growth
★ 3.11
N/A
52 Week Low
$12.85
$1.50
52 Week High
$32.42
$6.25

Technical Indicators

Market Signals
Indicator
MCS
SLBT
Relative Strength Index (RSI) 52.72 26.81
Support Level $26.52 N/A
Resistance Level $31.15 $3.36
Average True Range (ATR) 0.63 0.22
MACD 0.03 -0.04
Stochastic Oscillator 91.81 9.21

Price Performance

Historical Comparison
MCS
SLBT

About MCS Marcus Corporation (The)

Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.

About SLBT SL Science Holding Limited Ordinary Shares

SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

Share on Social Networks: